370 related articles for article (PubMed ID: 37108214)
1. Recent Advances in Genome-Editing Technology with CRISPR/Cas9 Variants and Stimuli-Responsive Targeting Approaches within Tumor Cells: A Future Perspective of Cancer Management.
Allemailem KS; Almatroodi SA; Almatroudi A; Alrumaihi F; Al Abdulmonem W; Al-Megrin WAI; Aljamaan AN; Rahmani AH; Khan AA
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108214
[TBL] [Abstract][Full Text] [Related]
2. Current updates of CRISPR/Cas9-mediated genome editing and targeting within tumor cells: an innovative strategy of cancer management.
Allemailem KS; Alsahli MA; Almatroudi A; Alrumaihi F; Alkhaleefah FK; Rahmani AH; Khan AA
Cancer Commun (Lond); 2022 Dec; 42(12):1257-1287. PubMed ID: 36209487
[TBL] [Abstract][Full Text] [Related]
3. Improving Plant Genome Editing with High-Fidelity xCas9 and Non-canonical PAM-Targeting Cas9-NG.
Zhong Z; Sretenovic S; Ren Q; Yang L; Bao Y; Qi C; Yuan M; He Y; Liu S; Liu X; Wang J; Huang L; Wang Y; Baby D; Wang D; Zhang T; Qi Y; Zhang Y
Mol Plant; 2019 Jul; 12(7):1027-1036. PubMed ID: 30928637
[TBL] [Abstract][Full Text] [Related]
4. Innovative Strategies of Reprogramming Immune System Cells by Targeting CRISPR/Cas9-Based Genome-Editing Tools: A New Era of Cancer Management.
Allemailem KS; Alsahli MA; Almatroudi A; Alrumaihi F; Al Abdulmonem W; Moawad AA; Alwanian WM; Almansour NM; Rahmani AH; Khan AA
Int J Nanomedicine; 2023; 18():5531-5559. PubMed ID: 37795042
[TBL] [Abstract][Full Text] [Related]
5. Expanding PAM recognition and enhancing base editing activity of Cas9 variants with non-PI domain mutations derived from xCas9.
Xie L; Hu Y; Li L; Jiang L; Jiao Y; Wang Y; Zhou L; Tao R; Qu J; Chen Q; Yao S
FEBS J; 2022 Oct; 289(19):5899-5913. PubMed ID: 35411720
[TBL] [Abstract][Full Text] [Related]
6. Prediction of the sequence-specific cleavage activity of Cas9 variants.
Kim N; Kim HK; Lee S; Seo JH; Choi JW; Park J; Min S; Yoon S; Cho SR; Kim HH
Nat Biotechnol; 2020 Nov; 38(11):1328-1336. PubMed ID: 32514125
[TBL] [Abstract][Full Text] [Related]
7. Genome Engineering in Rice Using Cas9 Variants that Recognize NG PAM Sequences.
Hua K; Tao X; Han P; Wang R; Zhu JK
Mol Plant; 2019 Jul; 12(7):1003-1014. PubMed ID: 30928636
[TBL] [Abstract][Full Text] [Related]
8. Targeted gene disruption by CRISPR/xCas9 system in Drosophila melanogaster.
Ni XY; Zhou ZD; Huang J; Qiao X
Arch Insect Biochem Physiol; 2020 May; 104(1):e21662. PubMed ID: 32027059
[TBL] [Abstract][Full Text] [Related]
9. Nanotechnology-based delivery of CRISPR/Cas9 for cancer treatment.
Xu X; Liu C; Wang Y; Koivisto O; Zhou J; Shu Y; Zhang H
Adv Drug Deliv Rev; 2021 Sep; 176():113891. PubMed ID: 34324887
[TBL] [Abstract][Full Text] [Related]
10. Recent Advances in Understanding the Molecular Mechanisms of Multidrug Resistance and Novel Approaches of CRISPR/Cas9-Based Genome-Editing to Combat This Health Emergency.
Allemailem KS
Int J Nanomedicine; 2024; 19():1125-1143. PubMed ID: 38344439
[TBL] [Abstract][Full Text] [Related]
11. Structural insights into a high fidelity variant of SpCas9.
Guo M; Ren K; Zhu Y; Tang Z; Wang Y; Zhang B; Huang Z
Cell Res; 2019 Mar; 29(3):183-192. PubMed ID: 30664728
[TBL] [Abstract][Full Text] [Related]
12. Expanding the scope of CRISPR/Cas9-mediated genome editing in plants using an xCas9 and Cas9-NG hybrid.
Niu Q; Wu S; Li Y; Yang X; Liu P; Xu Y; Lang Z
J Integr Plant Biol; 2020 Apr; 62(4):398-402. PubMed ID: 31702097
[TBL] [Abstract][Full Text] [Related]
13. Recent Updates of the CRISPR/Cas9 Genome Editing System: Novel Approaches to Regulate Its Spatiotemporal Control by Genetic and Physicochemical Strategies.
Allemailem KS; Almatroudi A; Rahmani AH; Alrumaihi F; Alradhi AE; Alsubaiyel AM; Algahtani M; Almousa RM; Mahzari A; Sindi AAA; Dobie G; Khan AA
Int J Nanomedicine; 2024; 19():5335-5363. PubMed ID: 38859956
[TBL] [Abstract][Full Text] [Related]
14. Stimuli-responsive nanoformulations for CRISPR-Cas9 genome editing.
Fang T; Cao X; Ibnat M; Chen G
J Nanobiotechnology; 2022 Aug; 20(1):354. PubMed ID: 35918694
[TBL] [Abstract][Full Text] [Related]
15. Increasing the efficiency of CRISPR-Cas9-VQR precise genome editing in rice.
Hu X; Meng X; Liu Q; Li J; Wang K
Plant Biotechnol J; 2018 Jan; 16(1):292-297. PubMed ID: 28605576
[TBL] [Abstract][Full Text] [Related]
16. Engineered Nanomaterials to Potentiate CRISPR/Cas9 Gene Editing for Cancer Therapy.
Yi K; Kong H; Lao YH; Li D; Mintz RL; Fang T; Chen G; Tao Y; Li M; Ding J
Adv Mater; 2024 Mar; 36(13):e2300665. PubMed ID: 37437039
[TBL] [Abstract][Full Text] [Related]
17. In-depth assessment of the PAM compatibility and editing activities of Cas9 variants.
Zhang W; Yin J; Zhang-Ding Z; Xin C; Liu M; Wang Y; Ai C; Hu J
Nucleic Acids Res; 2021 Sep; 49(15):8785-8795. PubMed ID: 34133740
[TBL] [Abstract][Full Text] [Related]
18. Spatiotemporal Delivery of CRISPR/Cas9 Genome Editing Machinery Using Stimuli-Responsive Vehicles.
Cai W; Luo T; Mao L; Wang M
Angew Chem Int Ed Engl; 2021 Apr; 60(16):8596-8606. PubMed ID: 32385892
[TBL] [Abstract][Full Text] [Related]
19. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
20. Boosting activity of high-fidelity CRISPR/Cas9 variants using a tRNA
He X; Wang Y; Yang F; Wang B; Xie H; Gu L; Zhao T; Liu X; Zhang D; Ren Q; Liu X; Liu Y; Gao C; Gu F
J Biol Chem; 2019 Jun; 294(23):9308-9315. PubMed ID: 31010827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
